
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions Corp demonstrates a robust underlying Crop Protection portfolio, maintaining strong international performance even with some market share decline in Argentina, and is well-positioned for a potential recovery in local farmer demand. The company has identified significant international revenue opportunities, particularly for its HB4 wheat products across the US, Brazil, and Australia, which are expected to contribute positively despite a gradual revenue ramp-up. Additionally, the company has seen strong sales momentum in bio-protection products and adjuvants in various international markets, effectively offsetting weaker domestic performance.
Bears say
Bioceres Crop Solutions Corp has demonstrated a significant decline in revenue, primarily driven by weaker demand for its Crop Protection and Crop Nutrition segments in Argentina, compounded by reduced contributions from HB4-related sales following a strategic shift to a licensing-based business model. Specifically, Crop Nutrition revenues decreased approximately 34% year-over-year to around $25 million, largely due to declining demand and pricing pressures in the fertilizer market, influenced by reduced corn acreage. Additionally, the Seed & Integrated products segment experienced a drastic revenue drop of approximately 75% year-over-year to around $8 million as the company transitioned its HB4 program, further exacerbating concerns regarding its financial stability.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares